Cell and gene therapy process maps – a first step towards industry standardization

Broadcast date

Tue, Jan 25, 2022

 

Presented by

    Jørgen Magnus - Bayer

 

Quick Description

BioPhorum’s Commercialization Workstream has generated a series of cell and gene therapy process maps containing example processes

Details

BioPhorum’s Commercialization Workstream has generated a series of cell and gene therapy process maps containing example processes, unit operations and platform technologies being used in manufacturing. The maps form a common frame of reference for scientists and engineers working within the field. They also encourage collaboration on process improvements that will benefit future cell therapy patients by supporting the acceleration of commercialization of novel modalities.

The purpose of this presentation is to provide insight into the complexity of cell and gene therapy (CGT) manufacture processes and to look at how BioPhorum is working collaboratively to address these. Learn about the process maps, created by industry leaders in the field, and how they can be used as an education tool for those new to CGT; a tool to help facilitate cross departmental and industry discussions. How can these maps be used to accelerate your in-house activities? Jorgen will demonstrate how his company has used the maps to support their own activity.

Speakers

Jørgen Magnus

Head of Bioprocess Technology

Bayer